530665 Stock Overview
Manufactures and trades pharmaceutical formulations in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Zenith Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹5.00 |
| 52 Week High | ₹6.87 |
| 52 Week Low | ₹3.61 |
| Beta | 1.68 |
| 1 Month Change | -3.29% |
| 3 Month Change | -15.54% |
| 1 Year Change | 25.31% |
| 3 Year Change | -43.37% |
| 5 Year Change | 354.55% |
| Change since IPO | 455.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| 530665 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -4.8% | -3.4% | -1.4% |
| 1Y | 25.3% | 18.6% | 5.8% |
Return vs Industry: 530665 exceeded the Indian Pharmaceuticals industry which returned 18.6% over the past year.
Return vs Market: 530665 exceeded the Indian Market which returned 5.8% over the past year.
Price Volatility
| 530665 volatility | |
|---|---|
| 530665 Average Weekly Movement | 5.7% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 530665 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 530665's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 40 | Mahendra Raycha | www.zenithhealthcare.com |
Zenith Healthcare Limited manufactures and trades pharmaceutical formulations in India. The company offers its products in the form of tablets, capsules, oral liquids, and injections in various therapeutic areas. It also engages in the contract manufacturing of various dosage forms.
Zenith Healthcare Limited Fundamentals Summary
| 530665 fundamental statistics | |
|---|---|
| Market cap | ₹266.55m |
| Earnings (TTM) | ₹911.00k |
| Revenue (TTM) | ₹127.20m |
294.9x
P/E Ratio2.1x
P/S RatioIs 530665 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 530665 income statement (TTM) | |
|---|---|
| Revenue | ₹127.20m |
| Cost of Revenue | ₹67.79m |
| Gross Profit | ₹59.41m |
| Other Expenses | ₹58.50m |
| Earnings | ₹911.00k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 11, 2025
| Earnings per share (EPS) | 0.017 |
| Gross Margin | 46.71% |
| Net Profit Margin | 0.72% |
| Debt/Equity Ratio | 0% |
How did 530665 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 13:39 |
| End of Day Share Price | 2025/01/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zenith Healthcare Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|